Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Price:
1 350.95
INR
0.72%
Market Closed
Market Cap:
1.1T
INR
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
DRREDDY Alert
Dr Reddy's Laboratories Ltd
1350.95
+9.60 (+0.72%)
| 52 Week Range |
1 092.5329
1 411.6
|
| Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Dr Reddy's Laboratories Ltd
Income Statement
Earnings Waterfall
Dr Reddy's Laboratories Ltd
Dr Reddy's Laboratories Ltd
|
Revenue
|
300.8B
INR
|
|
Cost of Revenue
|
-88.2B
INR
|
|
Gross Profit
|
212.7B
INR
|
|
Operating Expenses
|
-146.4B
INR
|
|
Operating Income
|
66.3B
INR
|
|
Other Expenses
|
-12.9B
INR
|
|
Net Income
|
53.4B
INR
|
Income Statement
Dr Reddy's Laboratories Ltd
Dr Reddy's Laboratories Ltd
Currency: INR
| Sep-2009 | Dec-2009 | Mar-2010 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||||||||||||||||||||
| Revenue |
74 613
N/A
|
73 700
-1%
|
70 310
-5%
|
37 728
-46%
|
77 935
+107%
|
117 732
+51%
|
155 683
+32%
|
150 401
-3%
|
146 357
-3%
|
143 792
-2%
|
141 961
-1%
|
142 846
+1%
|
142 281
0%
|
143 390
+1%
|
142 810
0%
|
146 843
+3%
|
149 420
+2%
|
149 725
+0%
|
154 482
+3%
|
155 699
+1%
|
165 652
+6%
|
170 977
+3%
|
175 170
+2%
|
180 853
+3%
|
181 834
+1%
|
187 282
+3%
|
190 475
+2%
|
195 661
+3%
|
204 421
+4%
|
208 385
+2%
|
215 452
+3%
|
218 330
+1%
|
223 779
+2%
|
238 294
+6%
|
246 697
+4%
|
261 947
+6%
|
267 655
+2%
|
272 125
+2%
|
280 111
+3%
|
289 493
+3%
|
300 849
+4%
|
|
| Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
| Cost of Revenue |
(25 737)
|
(25 251)
|
(24 108)
|
(8 852)
|
(18 133)
|
(27 936)
|
(44 636)
|
(38 720)
|
(38 113)
|
(36 469)
|
(42 082)
|
(38 993)
|
(40 688)
|
(42 896)
|
(45 203)
|
(40 852)
|
(41 000)
|
(42 391)
|
(49 796)
|
(46 968)
|
(50 462)
|
(52 857)
|
(60 126)
|
(56 671)
|
(58 461)
|
(60 685)
|
(65 647)
|
(64 614)
|
(69 089)
|
(70 859)
|
(79 972)
|
(76 514)
|
(74 708)
|
(76 575)
|
(83 048)
|
(76 840)
|
(78 400)
|
(80 146)
|
(89 398)
|
(84 528)
|
(88 165)
|
|
| Gross Profit |
48 876
N/A
|
48 449
-1%
|
46 202
-5%
|
28 876
-38%
|
59 802
+107%
|
89 796
+50%
|
111 047
+24%
|
111 681
+1%
|
108 244
-3%
|
107 323
-1%
|
99 879
-7%
|
103 853
+4%
|
101 593
-2%
|
100 494
-1%
|
97 607
-3%
|
105 991
+9%
|
108 420
+2%
|
107 334
-1%
|
104 686
-2%
|
108 731
+4%
|
115 190
+6%
|
118 120
+3%
|
115 044
-3%
|
124 182
+8%
|
123 373
-1%
|
126 597
+3%
|
124 828
-1%
|
131 047
+5%
|
135 332
+3%
|
137 526
+2%
|
135 480
-1%
|
141 816
+5%
|
149 071
+5%
|
161 719
+8%
|
163 649
+1%
|
185 107
+13%
|
189 255
+2%
|
191 979
+1%
|
190 713
-1%
|
204 965
+7%
|
212 684
+4%
|
|
| Operating Income | ||||||||||||||||||||||||||||||||||||||||||
| Operating Expenses |
(37 330)
|
(36 450)
|
(36 139)
|
(21 039)
|
(42 875)
|
(65 383)
|
(80 248)
|
(91 589)
|
(93 250)
|
(93 835)
|
(84 978)
|
(90 223)
|
(87 596)
|
(87 265)
|
(84 867)
|
(88 990)
|
(90 627)
|
(89 610)
|
(84 136)
|
(88 933)
|
(89 092)
|
(89 721)
|
(85 137)
|
(90 583)
|
(91 704)
|
(94 119)
|
(91 607)
|
(99 814)
|
(102 619)
|
(103 804)
|
(100 151)
|
(106 315)
|
(108 305)
|
(113 933)
|
(110 751)
|
(123 079)
|
(126 766)
|
(129 166)
|
(126 079)
|
(140 000)
|
(146 383)
|
|
| Selling, General & Administrative |
(11 417)
|
(11 571)
|
(18 743)
|
(10 632)
|
(21 496)
|
(32 391)
|
(54 026)
|
(42 687)
|
(43 189)
|
(43 585)
|
(56 054)
|
(42 493)
|
(42 045)
|
(42 292)
|
(56 703)
|
(53 562)
|
(62 709)
|
(70 013)
|
(58 399)
|
(77 482)
|
(77 296)
|
(77 959)
|
(58 810)
|
(78 919)
|
(80 006)
|
(82 178)
|
(63 851)
|
(87 610)
|
(90 639)
|
(91 994)
|
(73 399)
|
(94 551)
|
(96 390)
|
(101 723)
|
(82 048)
|
(110 062)
|
(113 086)
|
(114 988)
|
(92 026)
|
(125 027)
|
(131 195)
|
|
| Research & Development |
(4 007)
|
(3 872)
|
(3 731)
|
0
|
0
|
0
|
(16 927)
|
0
|
0
|
0
|
(18 658)
|
0
|
0
|
0
|
(17 392)
|
0
|
0
|
0
|
(14 389)
|
0
|
0
|
0
|
(14 696)
|
0
|
0
|
0
|
(15 468)
|
0
|
0
|
0
|
(15 100)
|
0
|
0
|
0
|
(16 201)
|
0
|
0
|
0
|
(19 353)
|
0
|
0
|
|
| Depreciation & Amortization |
(4 594)
|
(4 478)
|
(4 131)
|
(2 033)
|
(4 268)
|
(6 622)
|
(9 295)
|
(9 792)
|
(10 179)
|
(10 490)
|
(10 266)
|
(10 422)
|
(10 502)
|
(10 552)
|
(10 772)
|
(10 967)
|
(11 051)
|
(11 239)
|
(11 348)
|
(11 451)
|
(11 796)
|
(11 762)
|
(11 631)
|
(11 664)
|
(11 698)
|
(11 941)
|
(12 288)
|
(12 204)
|
(11 980)
|
(11 810)
|
(11 652)
|
(11 831)
|
(11 982)
|
(12 277)
|
(12 502)
|
(13 017)
|
(13 680)
|
(14 178)
|
(14 700)
|
(14 973)
|
(15 188)
|
|
| Other Operating Expenses |
(17 311)
|
(16 529)
|
(9 534)
|
(8 374)
|
(17 111)
|
(26 370)
|
0
|
(39 110)
|
(39 882)
|
(39 760)
|
0
|
(37 308)
|
(35 049)
|
(34 421)
|
0
|
(24 461)
|
(16 867)
|
(8 358)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
67
|
67
|
67
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
11 546
N/A
|
11 999
+4%
|
10 063
-16%
|
7 837
-22%
|
16 927
+116%
|
24 413
+44%
|
30 799
+26%
|
20 092
-35%
|
14 994
-25%
|
13 488
-10%
|
14 901
+10%
|
13 630
-9%
|
13 997
+3%
|
13 229
-5%
|
12 740
-4%
|
17 001
+33%
|
17 793
+5%
|
17 724
0%
|
20 550
+16%
|
19 798
-4%
|
26 098
+32%
|
28 399
+9%
|
29 907
+5%
|
33 599
+12%
|
31 669
-6%
|
32 478
+3%
|
33 221
+2%
|
31 233
-6%
|
32 713
+5%
|
33 722
+3%
|
35 329
+5%
|
35 501
+0%
|
40 766
+15%
|
47 786
+17%
|
52 898
+11%
|
62 028
+17%
|
62 489
+1%
|
62 813
+1%
|
64 634
+3%
|
64 965
+1%
|
66 301
+2%
|
|
| Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
| Interest Income Expense |
(674)
|
(480)
|
(312)
|
(281)
|
(496)
|
(656)
|
(2 287)
|
(693)
|
(604)
|
(608)
|
997
|
(701)
|
(798)
|
(806)
|
681
|
(768)
|
(753)
|
(822)
|
1 112
|
(829)
|
(807)
|
(542)
|
2 024
|
(443)
|
(436)
|
(497)
|
2 003
|
(361)
|
(169)
|
(163)
|
2 813
|
(481)
|
(663)
|
(990)
|
3 208
|
(1 133)
|
(1 275)
|
(1 284)
|
4 137
|
(1 775)
|
(2 160)
|
|
| Non-Reccuring Items |
(14 628)
|
(19 211)
|
(4 583)
|
0
|
0
|
0
|
(94)
|
0
|
(344)
|
(344)
|
(374)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(116)
|
0
|
(3 560)
|
(16 760)
|
(16 767)
|
(16 767)
|
(13 988)
|
(6 760)
|
(6 768)
|
(8 606)
|
(7 825)
|
(1 900)
|
(9 304)
|
(7 466)
|
(7 491)
|
(7 578)
|
(699)
|
(170)
|
784
|
808
|
(3)
|
987
|
(866)
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
460
|
460
|
1 257
|
0
|
0
|
0
|
(67)
|
0
|
0
|
0
|
(42)
|
0
|
0
|
0
|
1 119
|
0
|
0
|
0
|
(1 211)
|
0
|
0
|
0
|
900
|
0
|
0
|
|
| Total Other Income |
1 110
|
1 140
|
1 015
|
758
|
1 482
|
2 100
|
170
|
2 862
|
2 576
|
2 361
|
13
|
1 426
|
1 281
|
1 308
|
83
|
1 676
|
2 205
|
2 798
|
117
|
7 435
|
6 653
|
6 303
|
3 760
|
2 780
|
2 792
|
2 824
|
421
|
3 122
|
4 665
|
4 518
|
657
|
12 182
|
10 535
|
10 564
|
6 289
|
3 580
|
5 338
|
6 913
|
2 342
|
8 159
|
9 068
|
|
| Pre-Tax Income |
(2 647)
N/A
|
(6 553)
-148%
|
6 183
N/A
|
8 314
+34%
|
17 913
+115%
|
25 857
+44%
|
28 588
+11%
|
22 261
-22%
|
16 622
-25%
|
14 897
-10%
|
15 537
+4%
|
14 355
-8%
|
14 480
+1%
|
13 731
-5%
|
13 504
-2%
|
17 909
+33%
|
19 705
+10%
|
20 160
+2%
|
22 920
+14%
|
26 404
+15%
|
28 384
+7%
|
17 400
-39%
|
18 857
+8%
|
19 169
+2%
|
20 037
+5%
|
28 045
+40%
|
28 835
+3%
|
25 388
-12%
|
29 384
+16%
|
36 177
+23%
|
30 614
-15%
|
39 736
+30%
|
43 147
+9%
|
49 782
+15%
|
60 485
+21%
|
64 305
+6%
|
67 336
+5%
|
69 250
+3%
|
72 010
+4%
|
72 336
+0%
|
72 343
+0%
|
|
| Net Income | ||||||||||||||||||||||||||||||||||||||||||
| Tax Provision |
(3 523)
|
(3 540)
|
(2 668)
|
(1 888)
|
(3 797)
|
(5 948)
|
(7 511)
|
(6 149)
|
(5 196)
|
(4 430)
|
(2 965)
|
(2 676)
|
(2 843)
|
(3 113)
|
(3 111)
|
(3 406)
|
(3 090)
|
(2 446)
|
(3 855)
|
(5 251)
|
(6 226)
|
(5 540)
|
1 362
|
231
|
1 002
|
(1 343)
|
(9 632)
|
(8 014)
|
(9 770)
|
(9 749)
|
(8 833)
|
(9 825)
|
(12 052)
|
(13 341)
|
(15 412)
|
(17 072)
|
(16 423)
|
(16 967)
|
(16 231)
|
(16 683)
|
(18 093)
|
|
| Income from Continuing Operations |
(6 169)
|
(10 092)
|
3 515
|
6 426
|
14 116
|
19 909
|
21 077
|
16 112
|
11 426
|
10 467
|
12 572
|
11 679
|
11 637
|
10 618
|
10 393
|
14 503
|
16 615
|
17 714
|
19 065
|
21 153
|
22 158
|
11 860
|
20 219
|
19 400
|
21 039
|
26 702
|
19 203
|
17 374
|
19 614
|
26 428
|
21 781
|
29 911
|
31 095
|
36 441
|
45 073
|
47 233
|
50 913
|
52 283
|
55 779
|
55 653
|
54 250
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(862)
|
|
| Equity Earnings Affiliates |
0
|
0
|
0
|
49
|
106
|
170
|
229
|
253
|
281
|
306
|
349
|
374
|
381
|
377
|
344
|
329
|
346
|
350
|
438
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Income (Common) |
(6 170)
N/A
|
(10 093)
-64%
|
3 515
N/A
|
6 475
+84%
|
14 222
+120%
|
20 079
+41%
|
21 306
+6%
|
16 365
-23%
|
11 707
-28%
|
10 773
-8%
|
12 921
+20%
|
12 053
-7%
|
12 018
0%
|
10 122
-16%
|
9 468
-6%
|
13 563
+43%
|
15 692
+16%
|
17 668
+13%
|
19 500
+10%
|
21 505
+10%
|
27 390
+27%
|
17 003
-38%
|
20 260
+19%
|
19 441
-4%
|
16 091
-17%
|
21 754
+35%
|
19 516
-10%
|
17 374
-11%
|
19 614
+13%
|
26 428
+35%
|
21 825
-17%
|
29 911
+37%
|
31 095
+4%
|
36 441
+17%
|
45 073
+24%
|
47 233
+5%
|
50 913
+8%
|
52 283
+3%
|
55 779
+7%
|
55 653
0%
|
53 388
-4%
|
|
| EPS (Diluted) |
-36.29
N/A
|
-59.72
-65%
|
20.57
N/A
|
37.85
+84%
|
83.16
+120%
|
117.42
+41%
|
124.59
+6%
|
96.26
-23%
|
70.52
-27%
|
64.89
-8%
|
77.37
+19%
|
72.6
-6%
|
71.53
-1%
|
60.97
-15%
|
57.03
-6%
|
81.7
+43%
|
94.53
+16%
|
106.43
+13%
|
117.46
+10%
|
129.54
+10%
|
163.03
+26%
|
102.42
-37%
|
122.04
+19%
|
117.11
-4%
|
96.93
-17%
|
130.26
+34%
|
117.56
-10%
|
104.54
-11%
|
117.95
+13%
|
158.93
+35%
|
26.24
-83%
|
179.83
+585%
|
186.93
+4%
|
219.01
+17%
|
54.18
-75%
|
283.59
+423%
|
305.4
+8%
|
62.7
-79%
|
66.92
+7%
|
66.73
0%
|
64.08
-4%
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
